首页 工具
登录
购物车

搜索结果

Search Results for " adpkd "

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T12103 MR-L2

PDE Metabolism
MR-L2 是可逆的、非竞争性的长型异构体磷酸二酯酶 -4激活剂,可以激活代表性的 PDE4 长型异构体 (PDE4A4、PDE4B1、PDE4C3、PDE4D5)。它可抑制 PGE2- 诱导的 MDCK 细胞囊肿形成,其EC50=1.2 µM。
T64174 Vasopressin V2 receptor antagonist 1

Vasopressin V2 receptor antagonist 1 (Compound 4g) 是一种 vasopressin V2receptor (V2R) 拮抗剂 (Ki: 3.8 nM)。Vasopressin V2 receptor antagonist 1 可以用于研究常染色体显性多囊肾病 (ADPKD)。
T73163 CDK7-IN-20

CDK7-IN-20 是一种有效的、选择性的、不可逆的 CDK7(CDK) 抑制剂,IC50值为 4 nM。CDK7-IN-20 对 CDK7的选择性超过 CDK1、CDK2、CDK3、CDK5、CDK6、CDK9 和 CDK12的 206 倍以上。CDK7-IN-20 具有用于常染色体显性多囊肾病 (ADPKD) 研究的潜力。
T39712 RGLS4326

RG4326,RGLS4326

RGLS4326 (RG4326) is a short oligonucleotide inhibitor of microRNA-17 (miR-17), with a pioneering role in its class. This compound, with a research focus on autosomal dominant polycystic kidney disease (ADPKD), effectively suppresses the activity of miR-17 in HeLa cells, displaying an EC50 value of 28.3 nM.
T61362 CDK5-IN-3

CDK5-IN-3 (compound 11) is a highly potent and selective inhibitor of CDK5, demonstrating significant inhibition with IC50 values of 0.6 nM and 18 nM for CDK5/p25 and CDK2/CycA, respectively. This compound holds promise for further investigation in the context of autosomal dominant polycystic kidney disease (ADPKD) research [1].
T72076 H2-Gamendazole

HSP Cytoskeletal Signaling; Metabolism
H2-Gamendazole 是一种抑制精子发生和癌症治疗的新型化合物,可作为热休克蛋白和/或延伸因子1 α的抑制剂,是 Hsp90调节剂。

化合物

MR-L2
Cat.No: T12103
Synonym:
Target: PDE
Vasopressin V2 receptor antagonist 1
Cat.No: T64174
Synonym:
Target:
CDK7-IN-20
Cat.No: T73163
Synonym:
Target:
RGLS4326
Cat.No: T39712
Synonym: RG4326,RGLS4326
Target:
CDK5-IN-3
Cat.No: T61362
Synonym:
Target:
H2-Gamendazole
Cat.No: T72076
Synonym:
Target: HSP
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼